XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
  Impotence
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Impotence Channel
subscribe to Impotence newsletter

Latest Research : Urology : Impotence

   DISCUSS   |   EMAIL   |   PRINT
Mechanism of erectile dysfunction in diabetes
Aug 11, 2005, 16:55, Reviewed by: Dr.

Increased levels of eNOS-linked O-GlcNAc were detected, and significant decreases in the levels of both Ser-1177-phosphorylated eNOS and phosphorylated Akt, the upstream mediator of eNOS phosphorylation, were observed.

 
Biljana Musicki et al. demonstrate that the glycosylation of endothelial nitric oxide synthase (eNOS) by the monosaccharide O-GlcNAc inhibits proper erectile function in rats with type 1 diabetes. The phosphorylation of eNOS at Ser-1177 is an important step in the promotion of tumescence.

The enzyme's activity is regulated by extracellular stimuli including electrical stimulation, shear stress, and VEGF signaling. Previous research has shown that hyperglycemia-induced O-GlcNAc modification inhibits eNOS activity in blood vessels, but the physiologic relevance of this modification in diabetic vascular tissues is unclear. Musicki et al. induced diabetes in rats and examined the penile tissues of the animals.

Increased levels of eNOS-linked O-GlcNAc were detected, and significant decreases in the levels of both Ser-1177-phosphorylated eNOS and phosphorylated Akt, the upstream mediator of eNOS phosphorylation, were observed. Although electrical stimulation increased blood flow in penile tissue of control and diabetic rats, an increase in activated eNOS in diabetic rats was not seen.

VEGF administration and shear stress were similarly ineffective in the diabetic animals, with rates of full erectile status decreased by 40%, magnitude of erectile response decreased by 30%, and tumescence rise time decreased by 70%
 

- "Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction" by Biljana Musicki, Melissa F. Kramer, Robyn E. Becker, and Arthur L. Burnett
 

Full Text at Proceedings of the National Academy of Sciences

 
Subscribe to Impotence Newsletter
E-mail Address:

 



Related Impotence News

Smoking Increases the Risk of Erectile Dysfunction
Healthy lifestyle could fight erectile dysfunction
Erectle Dysfunction Common In Primary Care Patients
Erectile dysfunction (ED) also associated with other chronic diseases and their risk factors
Mechanism of erectile dysfunction in diabetes


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us